Search Results - "GREINACHER, A"

Refine Results
  1. 1

    Autoimmune heparin‐induced thrombocytopenia by Greinacher, A., Selleng, K., Warkentin, T. E.

    Published in Journal of thrombosis and haemostasis (01-11-2017)
    “…Summary Autoimmune heparin‐induced thrombocytopenia (aHIT) indicates the presence in patients of anti‐platelet factor 4 (PF4)–polyanion antibodies that are…”
    Get full text
    Journal Article
  2. 2

    Heparin‐induced thrombocytopenia by GREINACHER, A.

    Published in Journal of thrombosis and haemostasis (01-07-2009)
    “…Heparin‐induced thrombocytopenia (HIT), typically occurring in the second week of heparin therapy, is an antibody‐mediated adverse drug reaction associated…”
    Get full text
    Journal Article
  3. 3

    Immunogenic but effective: the HIT‐fondaparinux brain puzzler by GREINACHER, A.

    Published in Journal of thrombosis and haemostasis (01-12-2011)
    “…See also Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Fondaparinux treatment of acute heparininduced thrombocytopenia confirmed…”
    Get full text
    Journal Article
  4. 4

    Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA by Palankar, R., Kohler, T. P., Krauel, K., Wesche, J., Hammerschmidt, S., Greinacher, A.

    Published in Journal of thrombosis and haemostasis (01-06-2018)
    “…Essentials Human platelets specifically interact with IgG opsonized bacteria through FcγRIIA. Platelet factor 4 (PF4) binds to polyanions (P) and undergoes a…”
    Get full text
    Journal Article
  5. 5

    An open conformation of ADAMTS‐13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura by Roose, E., Schelpe, A. S., Joly, B. S., Peetermans, M., Verhamme, P., Voorberg, J., Greinacher, A., Deckmyn, H., De Meyer, S. F., Coppo, P., Veyradier, A., Vanhoorelbeke, K.

    Published in Journal of thrombosis and haemostasis (01-02-2018)
    “…Essentials Conformational changes in ADAMTS‐13 are part of its mode‐of‐action. The murine anti‐ADAMTS‐13 antibody 1C4 discriminates between folded and open…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings by LO, G. K., JUHL, D., WARKENTIN, T. E., SIGOUIN, C. S., EICHLER, P., GREINACHER, A.

    Published in Journal of thrombosis and haemostasis (01-04-2006)
    “…Background: Heparin‐induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction caused by heparin. As thrombocytopenia is common in hospitalized…”
    Get full text
    Journal Article
  9. 9

    Diagnosis of inherited platelet disorders on a blood smear: a tool to facilitate worldwide diagnosis of platelet disorders by Greinacher, A., Pecci, A., Kunishima, S., Althaus, K., Nurden, P., Balduini, C. L., Bakchoul, T.

    Published in Journal of thrombosis and haemostasis (01-07-2017)
    “…Essentials There are many hereditary platelet disorders (HPD) but diagnosing these is challenging. We provide a method to diagnose several HPDs using standard…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Early‐onset and persisting thrombocytopenia in post‐cardiac surgery patients is rarely due to heparin‐induced thrombocytopenia, even when antibody tests are positive by SELLENG, S., MALOWSKY, B., STROBEL, U., WESSEL, A., ITTERMANN, T., WOLLERT, H.‐G., WARKENTIN, T. E., GREINACHER, A.

    Published in Journal of thrombosis and haemostasis (01-01-2010)
    “…See also Gruel Y, Pouplard C. Post‐operative platelet count profile: the most reliable tool for identifying patients with true heparin‐induced thrombocypenia…”
    Get full text
    Journal Article
  12. 12

    Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes by GREINACHER, A., JUHL, D., STROBEL, U., WESSEL, A., LUBENOW, N., SELLENG, K., EICHLER, P., WARKENTIN, T. E.

    Published in Journal of thrombosis and haemostasis (01-08-2007)
    “…Introduction: Platelet‐activating antiplatelet factor 4/heparin (anti‐PF4/heparin) antibodies are the major cause of heparin‐induced thrombocytopenia (HIT)…”
    Get full text
    Journal Article
  13. 13

    Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non‐cardiac surgery: an observational cohort study by Baschin, M., Selleng, S., Hummel, A., Diedrich, S., Schroeder, H. W., Kohlmann, T., Westphal, A., Greinacher, A., Thiele, T.

    Published in Journal of thrombosis and haemostasis (01-04-2018)
    “…Essentials An increasing number of patients requiring surgery receive antiplatelet therapy (APT). We analyzed 181 patients receiving presurgery platelet…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Lepirudin in patients with heparin‐induced thrombocytopenia – results of the third prospective study (HAT‐3) and a combined analysis of HAT‐1, HAT‐2, and HAT‐3 by LUBENOW, N., EICHLER, P., LIETZ, T., GREINACHER, A.

    Published in Journal of thrombosis and haemostasis (01-11-2005)
    “…Objectives: To assess efficacy and safety of lepirudin in patients with heparin‐induced thrombocytopenia (HIT) in a prospective study (HAT‐3) as well as in a…”
    Get full text
    Journal Article
  16. 16

    Current insights into the laboratory diagnosis of HIT by Bakchoul, T., Zöllner, H., Greinacher, A.

    “…Summary Heparin‐induced thrombocytopenia (HIT) is an adverse drug reaction and prothrombotic disorder caused by immunization against platelet factor 4 (PF4)…”
    Get full text
    Journal Article
  17. 17

    Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia by GREINACHER, A, LUBENOW, N, EICHLER, P

    Published in Circulation (New York, N.Y.) (28-10-2003)
    “…Lepirudin (Refludan) is a hirudin derivative. It is a direct thrombin inhibitor obtained by recombinant technology from the medicinal leech and is approved for…”
    Get full text
    Journal Article
  18. 18

    Predonation finger lancet punctures: a potential risk factor for interdonor pathogen transmission in the blood donor clinic by Greinacher, A., Lubenow, N.

    Published in Vox sanguinis (01-07-2016)
    “…Background and Objectives Point‐of‐care testing using capillary blood from a finger prick is widely used for predonation haemoglobin testing of blood donors…”
    Get full text
    Journal Article
  19. 19

    Heparin‐induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests by GREINACHER, A., ITTERMANN, T., BAGEMÜHL, J., ALTHAUS, K., FÜRLL, B., SELLENG, S., LUBENOW, N., SCHELLONG, S., SHEPPARD, J. I., WARKENTIN, T.E.

    Published in Journal of thrombosis and haemostasis (01-09-2010)
    “…Background: Laboratory confirmation of heparin‐induced thrombocytopenia (HIT) is based on detection of heparin‐dependent platelet‐activating antibodies…”
    Get full text
    Journal Article
  20. 20